Choosing the best treatment strategy is often fraught with uncertainty. While some cancers have established protocols, others require personalized approaches. The genetic profile of a tumor can guide treatment but does not always predict response. Furthermore, the emergence of drug resistance can alter treatment efficacy over time, adding another layer of unpredictability.